Insert Therapeutics, Inc. Unidym, Inc. Tego BioSciences, Inc. Calando Pharmaceuticals, Inc.

Management Team

Arthur L. Swift
CEO & President, Unidym, Inc.

Mr. Swift brings over 20 years of senior management experience in the semiconductor industry to Unidym. Previously, Mr. Swift was President and CEO of Transmeta Corporation, an innovative semiconductor company in the Silicon Valley. Prior to his promotion to CEO, he was Senior Vice President of Marketing. At Transmeta, Mr. Swift was instrumental in transforming the company’s strategy from selling semiconductor chips to developing and licensing intellectual property.

Prior to Transmeta, Mr. Swift held senior leadership roles ranging from Office of the President and Chief Operating Officer at an embedded software startup, Lynuxworks, to Vice President and General Manager at a variety of large divisions of the established chip-maker Cirrus Logic. Art has also held senior marketing and engineering positions with Summit Microelectronics, Sun Microsystems, Digital Equipment, and Fairchild Semiconductor. Mr. Swift holds a B.S. in Electrical Engineering from the Pennsylvania State University.